Skip to main content

CORRECTION article

Front. Endocrinol., 19 December 2024
Sec. Pediatric Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1461564

Corrigendum: The role of oxidized lipid species in insulin resistance and NASH in children

This article is a correction to:

  1. The role of oxidized lipid species in insulin resistance and NASH in children

    1. Read original article
Nicola Santoro,,Nicola Santoro1,2,3Ariel E. Feldstein,*Ariel E. Feldstein4,5*
  • 1Department of Pediatrics, Kansas Medical Center, Kansas City, KS, United States
  • 2Department of Medicine and Health Sciences, “V.Tiberio” University of Molise, Campobasso, Italy
  • 3Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States
  • 4Department of Pediatrics, University of California San Diego, La Jolla, CA, United States
  • 5Global Drug Discovery, Novo Nordisk, Copenhagen, Denmark

A Corrigendum on
The role of oxidized lipid species in insulin resistance and NASH in children

By Santoro N and Feldstein AE (2022). Front. Endocrinol. 13:1019204. doi: 10.3389/fendo.2022.1019204

In the published article, there was an error regarding the affiliations for Ariel E. Feldstein. As well as having affiliation 4, they should also have “Global Drug Discovery, Novo Nordisk, Copenhagen, Denmark”.

In the published article, there was an error in the Conflicts of interest, and a declaration regarding author Ariel E. Feldstein was erroneously excluded.

The corrected Conflicts of interest section appears below.

“AF is an employee and stockholder of Novo Nordisk.

The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The author apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: lipids, PUFA (polyunsaturated fatty acids), NAFLD (nonalcoholic fatty liver disease), diabetes, children

Citation: Santoro N and Feldstein AE (2024) Corrigendum: The role of oxidized lipid species in insulin resistance and NASH in children. Front. Endocrinol. 15:1461564. doi: 10.3389/fendo.2024.1461564

Received: 08 July 2024; Accepted: 10 July 2024;
Published: 19 December 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Santoro and Feldstein. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ariel E. Feldstein, YWZlbGRzdGVpbkBoZWFsdGgudWNzZC5lZHU=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.